Generation of a human induced pluripotent stem cell (iPSC) line ERPLi004-A from an Alpha-1 antitrypsin deficiency (AATD) patient with SERPINA1 mutation
Alpha-1 antitrypsin deficiency (AATD) is an autosomal disorder that causes liver and lung disease. The risk of developing lung emphysema, chronic obstructive pulmonary disorder and liver cirrhosis is observed in >75 % people affected with a homozygous mutation. Here, we describe the generation of...
Saved in:
Main Authors: | Harshini Surendran, Rajani Battu, Renjitha Gopurappilly, Chethala N. Vishnuprasad, Rajarshi Pal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Stem Cell Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506125000145 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency
by: Brendan Connolly, et al.
Published: (2018-01-01) -
Unchain My Heart: Integrins at the Basis of iPSC Cardiomyocyte Differentiation
by: Rosaria Santoro, et al.
Published: (2019-01-01) -
iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
by: Jiepu Zong, et al.
Published: (2025-01-01) -
Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models
by: Rubén Fernández-Santiago, et al.
Published: (2016-01-01) -
Multitasking muscle: engineering iPSC-derived myogenic progenitors to do more
by: Mark Stephen Hamer, et al.
Published: (2025-01-01)